Will Junker, head of manufacturing quality at Kite Pharma, talks to Cell & Gene: The Podcast listeners about the challenges associated with capacity planning, partnering with CDMOs, and prioritizing inventory over time-to-market. Learn why a better understanding of the vector manufacturing process is critical to bringing continuous and secure supply to market. Listen now and subscribe so you never miss an episode!
Everything from glass or plastic bottles to the ink used in labels can leach unwanted contaminants. The first challenge chemists address is to narrow the focus on the most likely suspects.
Explore how surface plasmon resonance (SPR)-based analyses with a high sensitivity instrument can provide greater data precision and better confidence in your results interpretation.
As the industry looks forward, key decision makers in pharma and biotech companies were surveyed to assess their views on undertaking regulatory processes virtually.
A biotech with limited experience in the development and manufacture of high-potency compounds sought to develop a process for producing a highly potent API used to treat an unmet oncology need.
Biophysical characterization requires technologies that often needs expensive reagents, large quantities of samples, and experimental conditions optimization. Simplified analytical workflows can help.
The industry is now considering non-animal methods for toxicology studies. The move is toward more predictive models such as machine learning and organ-on-a-chip to drive safer and more efficient science.
We discuss the trends in new molecular formats, which is one of the current drivers of renewed interest in fermentation technologies, along with some of their challenges.
